Welcome to
On Feet Nation
smithmorgan Online
Steven Online
Wesley Online
Allen Online
QKSEO Online
goditac499 Online
Khalid Shaikh Online
terrance4sas Online
jack452 Online
The global Network Point-Of-Care Glucose Testing Market size is expected to reach USD 1.6 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 3.9% from 2021 to 2028. Some of the key players in this industry are F. Hoffmann-La Roche Ltd., Abbott, Nova Biomedical, Bayer AG/Ascensia Diabetes Care Holdings AG, Danaher. Increasing demand for safe and accurate remote patient monitoring options and the need for data-based treatment regimens are major factors driving the market. The integration of advanced technologies including Bluetooth Low Energy (BLE) and Infrared is expected to fuel the market growth in the upcoming years.
Expanding patient base in Asia Pacific and the Middle East and the high demand for advanced diabetes management systems are creating significant growth opportunities in these regions. These regions also include some of the highly preferred destinations for medical tourism. Increasing demand for world-class healthcare services and rising adoption of advanced technology are some of the factors boosting the market growth in these regions.
Network point-of-care glucose meters were extensively used in COVID-19 care. This enabled doctors to remotely observe glucose levels with minimal risk of infection. In addition, a large amount of data is still being used to customize treatment plans for diabetic COVID-19 patients. Preference for telemedicine and trends of home healthcare settings for chronic patients are some of the factors expected to expand the applications of network-based point-of-care devices.
Related Press Release@ Network Point-of-Care Glucose Testing Market Report
Network Point-of-Care Glucose Testing Market Report Highlights
© 2024 Created by PH the vintage. Powered by
You need to be a member of On Feet Nation to add comments!
Join On Feet Nation